Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4799843
Max Phase: Preclinical
Molecular Formula: C21H16N2O5S
Molecular Weight: 408.44
Molecule Type: Unknown
Associated Items:
ID: ALA4799843
Max Phase: Preclinical
Molecular Formula: C21H16N2O5S
Molecular Weight: 408.44
Molecule Type: Unknown
Associated Items:
Canonical SMILES: N[C@H]1CCN(C(=O)c2csc3c(O)c4c(c(O)c23)C(=O)c2ccccc2C4=O)C1
Standard InChI: InChI=1S/C21H16N2O5S/c22-9-5-6-23(7-9)21(28)12-8-29-20-13(12)18(26)14-15(19(20)27)17(25)11-4-2-1-3-10(11)16(14)24/h1-4,8-9,26-27H,5-7,22H2/t9-/m0/s1
Standard InChI Key: CIYYLIRNMOJGCH-VIFPVBQESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 408.44 | Molecular Weight (Monoisotopic): 408.0780 | AlogP: 2.26 | #Rotatable Bonds: 1 |
Polar Surface Area: 120.93 | Molecular Species: BASE | HBA: 7 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.04 | CX Basic pKa: 9.26 | CX LogP: 2.00 | CX LogD: 1.99 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.42 | Np Likeness Score: -0.33 |
1. Tikhomirov AS,Litvinova VA,Andreeva DV,Tsvetkov VB,Dezhenkova LG,Volodina YL,Kaluzhny DN,Treshalin ID,Schols D,Ramonova AA,Moisenovich MM,Shtil AA,Shchekotikhin AE. (2020) Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties., 199 [PMID:32428792] [10.1016/j.ejmech.2020.112294] |
2. Volodina YL, Tikhomirov AS, Dezhenkova LG, Ramonova AA, Kononova AV, Andreeva DV, Kaluzhny DN, Schols D, Moisenovich MM, Shchekotikhin AE, Shtil AA.. (2021) Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype., 221 [PMID:34082225] [10.1016/j.ejmech.2021.113521] |
Source(1):